Market Analysis and Price Projections for the Drug NDC: 00904-7177
Introduction to NDC 00904-7177
The National Drug Code (NDC) 00904-7177 corresponds to Furosemide, a diuretic medication manufactured by Major Pharmaceuticals. This drug is widely used to treat edema and hypertension by increasing urine production.
Market Context
Pharmaceutical Market Growth
The US pharmaceutical market, which includes drugs like Furosemide, is projected to grow significantly. By 2030, the market is expected to reach $1.28 trillion from $846.72 billion in 2022, with a Compound Annual Growth Rate (CAGR) of 5.36%. This growth is driven by factors such as rising pharmaceutical production capacity, greater approvals of generic drugs, and escalating R&D investments[2].
Biopharma and Biotech Trends
While Furosemide is not a biopharmaceutical, the broader pharmaceutical market is influenced by trends in the biopharma and biotech sectors. These industries are growing rapidly, with the biopharma market projected to have a CAGR of 7.56% between 2024 and 2029, and the biotech market expected to grow at a CAGR of 9.4% between 2021 and 2027. These growth rates are driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care[3].
Pricing Mechanisms
Average Manufacturer Price (AMP) and Unit Rebate Amount (URA)
For drugs covered under the Medicaid Drug Rebate Program, the pricing mechanism involves calculating the Average Manufacturer Price (AMP) and the Unit Rebate Amount (URA). The 340B ceiling price is determined by subtracting the URA from the AMP, then adjusting for package size and case pack size[2].
Example Calculation
While specific AMP and URA data for NDC 00904-7177 are not provided, here is a hypothetical example to illustrate the calculation:
- AMP: $10 per unit
- URA: $2 per unit
- Package Size: 100 units
- Case Pack Size: 5 packages
[ \text{340B Ceiling Price} = (10 - 2) \times 100 \times 5 = \$4000 ]
This calculation provides a baseline for the ceiling price, but actual market prices can vary based on market demand, competition, and regulatory changes.
Factors Influencing Price Projections
Historical Pricing Data
Reviewing historical pricing data for Furosemide can provide insights into price trends and potential future adjustments. For instance, if the price has been stable or decreasing over time, it may indicate a competitive market or high generic penetration[2].
Regulatory Changes
Changes in regulatory policies, such as updates to the Medicaid Drug Rebate Program or new FDA guidelines, can impact pricing. For example, changes in rebate requirements or new labeling regulations could affect the cost structure of the drug[2].
Market Demand and Competition
The demand for Furosemide and the level of competition in the market significantly influence pricing. Since Furosemide is a generic drug with multiple manufacturers, competition is high, which typically keeps prices stable or low. However, any changes in demand due to new treatment guidelines or the introduction of new competing drugs could impact pricing[2].
Technological Advancements
Technological advancements, such as the adoption of AI in drug development and manufacturing, can reduce costs and potentially lead to lower prices. However, for a well-established generic drug like Furosemide, the impact of such advancements may be minimal[2].
Market Analysis for Furosemide
Current Market Status
Furosemide is a widely used generic drug, and its market is characterized by high competition. Major Pharmaceuticals, along with other manufacturers, produces this drug, which helps keep prices competitive.
Sales Projections
Given the stable demand for diuretics and the competitive nature of the generic drug market, sales projections for Furosemide are likely to remain steady. There is no significant indication that the sales of Furosemide will increase dramatically unless there are changes in treatment guidelines or a sudden increase in the prevalence of conditions it treats.
Price Stability
The price of Furosemide is expected to remain stable due to the high level of competition in the generic drug market. Here is an example of how prices might look:
| NDC |
Drug Name |
Price/Unit ($) |
Date |
| 00904-7177 |
Furosemide |
0.50 - 1.00 |
2024-12-18 |
Prices can vary slightly based on the vendor, package size, and other factors, but overall, they tend to be stable and low due to generic competition[1].
Key Takeaways
- Market Growth: The US pharmaceutical market is projected to grow significantly by 2030.
- Pricing Mechanisms: AMP and URA are key in calculating ceiling prices for covered outpatient drugs.
- Market Demand: High competition in the generic drug market keeps prices stable and low.
- Regulatory Changes: Updates in regulatory policies can impact pricing.
- Technological Advancements: While impactful in drug development, these have minimal effect on established generic drugs like Furosemide.
FAQs
What is the NDC 00904-7177?
The NDC 00904-7177 corresponds to Furosemide, a diuretic medication manufactured by Major Pharmaceuticals.
How is the price of Furosemide calculated?
The price of Furosemide, especially for Medicaid-covered entities, is calculated using the Average Manufacturer Price (AMP) and Unit Rebate Amount (URA), adjusted for package and case pack sizes.
What factors influence the price of Furosemide?
Historical pricing data, regulatory changes, market demand, competition, and technological advancements influence the price of Furosemide.
Is the price of Furosemide expected to change significantly?
No, the price of Furosemide is expected to remain stable due to high competition in the generic drug market.
How does the US pharmaceutical market growth impact Furosemide sales?
The overall growth of the US pharmaceutical market does not significantly impact the sales of Furosemide, as it is a well-established generic drug with stable demand.
Sources
- FindACode: Major Pharmaceuticals - List of Drugs - NDC Labeler/Manufacturer.
- DrugPatentWatch: Latest pharmaceutical drug prices and trends for NDC 00093-7662.
- TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025.
- GlobalData: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
- DrugPatentWatch: Latest pharmaceutical drug prices and trends for NDC 00781-7177.
